What to know about new diagnostic tools, targeted medications, and other recent advances in the treatment of metastatic NSCLC ...

The MRI shows a brain tumor in an inauspicious location, and a brain biopsy will entail high risks for a patient who had ...

Rova-T’s limited efficacy in glioblastoma—attributed to suboptimal tumor penetration and compensatory signaling—exemplifies these challenges (122, 123). Figure 2. Future Directions in DLL3-Targeted ...

1Key Laboratory of Multi-Cell Systems, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China. Search for ...

The U.S. Food and Drug Administration has approved AbbVie's drug to treat adults with a type of lung cancer who have received previous treatment, the drugmaker said on Wednesday.

After flexing its antibody-drug conjugate bona fides at last year’s American Society of Clinical Oncology (ASCO) conference, AbbVie is advancing its solid tumor ambitions with a new FDA green light.